T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.25B |
| 2 |
Sea Limited
SE
|
+$1.98B |
| 3 |
Morgan Stanley
MS
|
+$1.41B |
| 4 |
Incyte
INCY
|
+$1.13B |
| 5 |
Ross Stores
ROST
|
+$911M |
Top Sells
| 1 |
Boeing
BA
|
+$2.44B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.68B |
| 3 |
Visa
V
|
+$1.23B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
JPMorgan Chase
JPM
|
+$1.12B |
Sector Composition
| 1 | Technology | 25.02% |
| 2 | Healthcare | 17.61% |
| 3 | Consumer Discretionary | 14.48% |
| 4 | Financials | 11.79% |
| 5 | Communication Services | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Esperion Therapeutics
ESPR
$573M
| $9.51M | ﹤0.01% |
185,327
-15,515
| -8% | -$796K |
|
1302
Puma Biotechnology
PBYI
$225M
| $9.44M | ﹤0.01% |
905,357
-130,254
| -13% | -$1.36M |
|
|
PBCT
1303
DELISTED
People's United Financial Inc
PBCT
| $9.42M | ﹤0.01% |
814,344
-62,217
| -7% | -$720K |
|
1304
Markel Group
MKL
$24.7B
| $9.34M | ﹤0.01% |
10,117
-164
| -2% | -$151K |
|
1305
Stoke Therapeutics
STOK
$1.29B
| $9.33M | ﹤0.01% |
391,358
-36,164
| -8% | -$862K |
|
1306
Leggett & Platt
LEG
$1.3B
| $9.16M | ﹤0.01% |
260,660
-9,363
| -3% | -$329K |
|
|
AMK
1307
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $9.13M | ﹤0.01% |
334,582
-33,515
| -9% | -$915K |
|
1308
FRP Holdings
FRPH
$483M
| $9.05M | ﹤0.01% |
445,802
+470
| +0.1% | +$9.54K |
|
1309
OneSpaWorld
OSW
$2.24B
| $8.91M | ﹤0.01% |
1,867,798
-1,333,264
| -42% | -$6.36M |
|
|
EXPR
1310
DELISTED
Express, Inc.
EXPR
| $8.88M | ﹤0.01% |
288,350
+43,430
| +18% | +$1.34M |
|
1311
Invitation Homes
INVH
$18.5B
| $8.83M | ﹤0.01% |
320,697
-49,128
| -13% | -$1.35M |
|
1312
Axalta
AXTA
$6.75B
| $8.8M | ﹤0.01% |
390,408
-44,251
| -10% | -$998K |
|
1313
Ambev
ABEV
$35.9B
| $8.66M | ﹤0.01% |
3,280,700
-599,000
| -15% | -$1.58M |
|
1314
NOV
NOV
$4.79B
| $8.61M | ﹤0.01% |
702,668
-69,215
| -9% | -$848K |
|
1315
Orion
OEC
$521M
| $8.59M | ﹤0.01% |
811,134
+245,308
| +43% | +$2.6M |
|
1316
Utz Brands
UTZ
$1.12B
| $8.49M | ﹤0.01% |
+619,543
| New | +$8.49M |
|
|
MRO
1317
DELISTED
Marathon Oil Corporation
MRO
| $8.46M | ﹤0.01% |
1,382,979
-181,664
| -12% | -$1.11M |
|
|
LDL
1318
DELISTED
Lydall, Inc.
LDL
| $8.46M | ﹤0.01% |
623,996
-6,048
| -1% | -$82K |
|
1319
STRATTEC Security
STRT
$283M
| $8.4M | ﹤0.01% |
526,981
+13,433
| +3% | +$214K |
|
|
NBL
1320
DELISTED
Noble Energy, Inc.
NBL
| $8.3M | ﹤0.01% |
925,811
-23,902
| -3% | -$214K |
|
|
CNST
1321
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $8.24M | ﹤0.01% |
274,039
-253,828
| -48% | -$7.63M |
|
1322
Globant
GLOB
$2.47B
| $8.22M | ﹤0.01% |
54,876
-4,234
| -7% | -$634K |
|
1323
The Mosaic Company
MOS
$10.7B
| $8.17M | ﹤0.01% |
653,349
-35,726
| -5% | -$447K |
|
1324
Trade Desk
TTD
$22.1B
| $8.17M | ﹤0.01% |
201,050
-5,230
| -3% | -$213K |
|
1325
National Vision
EYE
$1.82B
| $8.14M | ﹤0.01% |
266,599
+31,408
| +13% | +$959K |
|